为æ¢è®¨é»è©è·å¯¹èå¤ç³(LPS)诱导çå¤§é¼ å¿èç»èå亡,ççå磷èé
°èé3-æ¿é
¶(PI3K)/èç½æ¿é
¶B(AKT)ä¿¡å·éè·¯çè°æ§ä½ç¨,该ç ç©¶ä½å¤å¹å
»å¤§é¼ å¿èH9C2ç»è,å°å
¶å为对ç
§ç»(ä¸åå¹²é¢),LPSç»(10μg/mL LPS),å®éªç»(10μg/mL LPS+10,20,40,80μmol/Lé»è©è·),é»è©è·+Yç»(10μg/mL LPS+10μmol/Lé»è©è·+5μmol/L PI3K/AKTéè·¯æå¶åLY294002),æå¶åç»(10μg/mLLPS+5μmol/L LY294002)åé»è©è·+Aç»[10μg/mL LPS+10μmol/Lé»è©è·+100 ng/mL PI3K/AKTéè·¯æ¿æ´»åè°å²ç´ æ ·çé¿å å-I(IGF-I)].ç¨ç»è计æ°è¯åç-8æµå®ç»èæ´»å;é
¶èå
ç«å¸éè¯éªæ£æµççå åç½ç»èä»ç´ -1β(IL-1β),IL-6åIL-10çå«é;Hoechst33258æè²æ³æµå®ç»èå亡ç;5-ä¹çåº-2 è±æ°§å°¿å§å¶æ ¸è·æµå®ç»è墿®ç;èç½å
ç«å°è¿¹æ³æµå®PI3K/AKTç¸å
³èç½,ç»è卿èç½D1(CyclinD1)ååè±æ°¨é
¸å¤©å¬æ°¨é
¸èç½é
¶-3(Caspase-3)èç½è¡¨è¾¾æ°´å¹³.ç»æè¡¨æ,ä¸å¯¹ç
§ç»ç¸æ¯,LPSç»ç»èæ´»åæ¾èéä½(P<0.05),ä¸LPSç»ç¸æ¯,10μg/mL LPS+10μmol/Lé»è©è·ç»ç»èæ´»åæ¾èåé«(P<0.05),å æ¤éæ©10μmol/Lé»è©è·è¿è¡åç»å®éª.ä¸å¯¹ç
§ç»ç¸æ¯,LPSç»IL-10å«é,ç»è墿®ç,CyclinD1èç½è¡¨è¾¾æ°´å¹³æ¾èéä½(P<0.05),IL-6å«é,IL-1βå«é,ç»èå亡ç,Caspase-3,p-PI3Kåp-AKTèç½è¡¨è¾¾æ°´å¹³æ¾èåé«(P<0.05);ä¸LPSç»ç¸æ¯,é»è©è·ç»(å³10μg/mL LPS+10μmol/Lé»è©è·ç»)åæå¶åç»H9C2ç»èä¸ä¸è¿°ææ çååè¶å¿è¢«æ¾èæè½¬äº(P<0.05);ä¸é»è©è·ç»ç¸æ¯,é»è©è·+Yç»IL-10å«é,ç»è墿®ç,CyclinD1èç½è¡¨è¾¾æ°´å¹³æ¾èåé«(P<0.05),IL-6åIL-1βå«é,ç»èå亡ç,Caspase-3,p-PI3Kåp-AKTèç½è¡¨è¾¾æ°´å¹³æ¾èéä½(P<0.05);é»è©è·+Aç»ä¸é»è©è·+Yç»ææ ååæ
åµç¸å(P<0.05).æ»ä¹,é»è©è·å¯éè¿é»æPI3K/AKTéè·¯çä¿¡å·è½¬å¯¼æå¶LPS诱导çå¤§é¼ å¿èH9C2ç»èçå亡åççååº.